EPO and glaucoma: A rat model of glaucoma induced using episcleral vessel cautery (EVC) was used to evaluate the potential neuroprotective effect of an IVI of recombinant rat EPO by Tsai et al., who found that the RGC counts in retinal specimens were significantly decreased in the EVC with and without intravitreal normal saline injection groups compared to unoperated control rats.